Poolbeg Pharma announces an update to its Oral Vaccine Programme following the award of non-dilutive grant funding by the Irish Government’s Disruptive Technologies Innovation Fund in November 2022, as part of the Poolbeg led EncOVac Consortium.
Poolbeg Pharma PLC – Oral Vaccine Programme Moves Forward Read More »
GSK plc announced that the US Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted in favor of recommending the use of AREXVY in adults aged 60 and older using shared clinical decision making.
AssayQuant® Technologies, Inc. introduces KinSight™ Kinome Profiling Services providing superior results including kinetic insights into selectivity and mechanisms of action for drug discovery.
Kinetic Insights with AssayQuant’s Fully Automated KinSight™ Kinome Profiling Services Read More »
Ferring Pharmaceuticals announced that Jean-Frédéric Paulsen has been appointed Executive Chairman of the Ferring Group, as it enters a new phase of growth following the approval of two innovative medicines by the US Food and Drug Administration.
Tagworks Pharmaceuticals BV announced a $65 million Series A financing led by Ysios Capital and Gilde Healthcare with participation from Novartis Venture Fund, New Enterprise Associates, and Lightstone Ventures.
Memo Therapeutics AG, a late-stage biotech company developing best-in-class therapeutic antibodies, announced that the first patient has been enrolled in a pivotal, multicenter U.S. Phase II/III trial of AntiBKV, MTx’s antibody therapeutic that targets BK polyomavirus infection in renal transplant patients.
On the heels of Merck’s and BMS’s lawsuits, the pharma industry’s lobbying group Wednesday filed a complaint in federal court asserting that the price-setting provisions in the Inflation Reduction Act are unconstitutional.
PhRMA Joins Merck, BMS in Latest Lawsuit Challenging IRA’s Drug Price Negotiations Read More »
An analysis by KFF found state spending on Medicaid fell during the COVID-19 pandemic even as enrollment soared. But spending will likely increase as the federal government begins to pare back its increased contribution.
State Medicaid spending fell below pre-pandemic levels during continuous enrollment Read More »
The healthcare workers union said the findings raise questions about potential corporate interference to decrease the number of patients who die in HCA hospitals, and urged both HCA and regulators to investigate.
At least six companies have emerged to help unstick what developers say is a “bottleneck” in advancing complex genetic treatments.
Cell and gene therapy manufacturing: the next generation of startups Read More »
